Preliminary Amendment

LOKAVANT

Roivant Sciences GmbH

Preliminary Amendment

Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1966 (Rev 10/2011)
OMB No. 0651-0050 (Exp 09/20/2020)

Voluntary Amendment


The table below presents the data as entered.

Input Field
Entered
SERIAL NUMBER 88703456
MARK SECTION
MARK http://uspto.report/TM/88703456/mark.png
LITERAL ELEMENT LOKAVANT
STANDARD CHARACTERS YES
USPTO-GENERATED IMAGE YES
MARK STATEMENT The mark consists of standard characters, without claim to any particular font style, size or color.
GOODS AND/OR SERVICES SECTION (009)(current)
INTERNATIONAL CLASS 009
DESCRIPTION
Computer software; computer software for providing, analyzing and generating reports; computer software for data processing; software, programs and systems for the capture, collection, conversion, analysis, communication, processing, receiving, recording, storage and/or transmission of data, images and information; software, programs and systems for the conversion, analysis, processing, storage and transmission of artificial intelligence; computer software for database integration; computer software for creating searchable databases of information and data; software for analytics in the fields of healthcare, pharmaceuticals, biomedicine, pharmaceutical and biomedical research and development, and for clinical trial and post-market trial data; downloadable computer software featuring electronic computer databases of pharmaceuticals, biomedical research, and for clinical trial and post-market trial data; downloadable computer search engine software for compiling, accessing and providing updated scientific, medical, pharmaceutical, biomedical and clinical information, and news information of general interest; computer software for managing and analyzing clinical trial and clinical research workflow; computer software for use in collecting and managing data in the field of biomedical research; software for biomedical and clinical research services; database management software for use in biomedical and clinical and medical research
FILING BASIS Section 44(d)
        FOREIGN APPLICATION NUMBER 08745/2019
       FOREIGN APPLICATION COUNTRY Switzerland
        FOREIGN FILING DATE 06/28/2019
GOODS AND/OR SERVICES SECTION (009)(proposed)
INTERNATIONAL CLASS 009
DESCRIPTION
Computer software; computer software for providing, analyzing and generating reports; computer software for data processing; software, programs and systems for the capture, collection, conversion, analysis, communication, processing, receiving, recording, storage and/or transmission of data, images and information; software, programs and systems for the conversion, analysis, processing, storage and transmission of artificial intelligence; computer software for database integration; computer software for creating searchable databases of information and data; software for analytics in the fields of healthcare, pharmaceuticals, biomedicine, pharmaceutical and biomedical research and development, and for clinical trial and post-market trial data; downloadable computer software featuring electronic computer databases of pharmaceuticals, biomedical research, and for clinical trial and post-market trial data; downloadable computer search engine software for compiling, accessing and providing updated scientific, medical, pharmaceutical, biomedical and clinical information, and news information of general interest; computer software for managing and analyzing clinical trial and clinical research workflow; computer software for use in collecting and managing data in the field of biomedical research; software for biomedical and clinical research services; database management software for use in biomedical and clinical and medical research
FILING BASIS Section 44(d)
       FOREIGN APPLICATION NUMBER 08745/2019
       FOREIGN APPLICATION COUNTRY Switzerland
       FOREIGN FILING DATE 06/28/2019
       INTENT TO
       PERFECT 44(d)
At this time, the applicant intends to rely on Section 44(e) as a basis for registration and requests that the application be suspended to await the submission of the foreign registration. If ultimately the applicant does not rely on §44(e) as a basis for registration, a valid claim of priority may be retained.
FILING BASIS Section 44(e)
       FOREIGN REGISTRATION NUMBER 740044
       FOREIGN REGISTRATION
       COUNTRY
Switzerland
       FOREIGN REGISTRATION
       DATE
12/11/2019
       FOREIGN EXPIRATION DATE 06/28/2029
       FOREIGN REGISTRATION FILE NAME(S)
       ORIGINAL PDF FILE FRU0-3810821634-093810290_._Swiss_registration_for_LOKAVANT__F3329004x96B9E_.pdf
       CONVERTED PDF FILE(S)
       (6 pages)
\\TICRS\EXPORT17\IMAGEOUT17\887\034\88703456\xml2\PRA0002.JPG
        \\TICRS\EXPORT17\IMAGEOUT17\887\034\88703456\xml2\PRA0003.JPG
        \\TICRS\EXPORT17\IMAGEOUT17\887\034\88703456\xml2\PRA0004.JPG
        \\TICRS\EXPORT17\IMAGEOUT17\887\034\88703456\xml2\PRA0005.JPG
        \\TICRS\EXPORT17\IMAGEOUT17\887\034\88703456\xml2\PRA0006.JPG
        \\TICRS\EXPORT17\IMAGEOUT17\887\034\88703456\xml2\PRA0007.JPG
       STANDARD CHARACTERS
       OR EQUIVALENT
YES
GOODS AND/OR SERVICES SECTION (035)(current)
INTERNATIONAL CLASS 035
DESCRIPTION
Advertising; business management; business administration; office functions; business research services; business information services; market research; provision of market research information; data processing services; analysis of business data; artificial intelligence and machine learning statistical analysis, consultancy and reporting for pharmaceutical and biomedical research; business analysis and statistical analysis of healthcare data, pharmaceuticals, biomedical research, and for clinical trial and post-market data; systematization and compilation of data in computer databases, in particular compilation of information into computer databases for research and analysis purposes in the field of healthcare, pharmaceuticals, biomedicine, pharmaceutical and biomedical research and development, clinical trials and post-market data; professional business analysis and consultancy and statistical analysis in the fields of healthcare, pharmaceuticals, biomedicine, clinical trials, epidemiological research, pharmacoepidemiological research, post-market trials and research evaluating epidemiological outcomes
FILING BASIS Section 44(d)
        FOREIGN APPLICATION NUMBER 08745/2019
       FOREIGN APPLICATION COUNTRY Switzerland
        FOREIGN FILING DATE 06/28/2019
GOODS AND/OR SERVICES SECTION (035)(proposed)
INTERNATIONAL CLASS 035
DESCRIPTION
Advertising; business management; business administration; office functions; business research services; business information services; market research; provision of market research information; data processing services; analysis of business data; artificial intelligence and machine learning statistical analysis, consultancy and reporting for pharmaceutical and biomedical research; business analysis and statistical analysis of healthcare data, pharmaceuticals, biomedical research, and for clinical trial and post-market data; systematization and compilation of data in computer databases, in particular compilation of information into computer databases for research and analysis purposes in the field of healthcare, pharmaceuticals, biomedicine, pharmaceutical and biomedical research and development, clinical trials and post-market data; professional business analysis and consultancy and statistical analysis in the fields of healthcare, pharmaceuticals, biomedicine, clinical trials, epidemiological research, pharmacoepidemiological research, post-market trials and research evaluating epidemiological outcomes
FILING BASIS Section 44(d)
       FOREIGN APPLICATION NUMBER 08745/2019
       FOREIGN APPLICATION COUNTRY Switzerland
       FOREIGN FILING DATE 06/28/2019
       INTENT TO
       PERFECT 44(d)
At this time, the applicant intends to rely on Section 44(e) as a basis for registration and requests that the application be suspended to await the submission of the foreign registration. If ultimately the applicant does not rely on §44(e) as a basis for registration, a valid claim of priority may be retained.
FILING BASIS Section 44(e)
       FOREIGN REGISTRATION NUMBER 740044
       FOREIGN REGISTRATION
       COUNTRY
Switzerland
       FOREIGN REGISTRATION
       DATE
12/11/2019
       FOREIGN EXPIRATION DATE 06/28/2029
       FOREIGN REGISTRATION FILE NAME(S)
       ORIGINAL PDF FILE FRU1-3810821634-093810290_._Swiss_registration_for_LOKAVANT__F3329004x96B9E_.pdf
       CONVERTED PDF FILE(S)
       (6 pages)
\\TICRS\EXPORT17\IMAGEOUT17\887\034\88703456\xml2\PRA0008.JPG
        \\TICRS\EXPORT17\IMAGEOUT17\887\034\88703456\xml2\PRA0009.JPG
        \\TICRS\EXPORT17\IMAGEOUT17\887\034\88703456\xml2\PRA0010.JPG
        \\TICRS\EXPORT17\IMAGEOUT17\887\034\88703456\xml2\PRA0011.JPG
        \\TICRS\EXPORT17\IMAGEOUT17\887\034\88703456\xml2\PRA0012.JPG
        \\TICRS\EXPORT17\IMAGEOUT17\887\034\88703456\xml2\PRA0013.JPG
       STANDARD CHARACTERS
       OR EQUIVALENT
YES
GOODS AND/OR SERVICES SECTION (042)(current)
INTERNATIONAL CLASS 042
DESCRIPTION
Scientific and technological services and research and design relating thereto; analysis of technical data by computers; pharmaceutical, biomedical, biological therapeutic research services; research in the field of pharmaceutical and biologic therapeutic preparations; pharmaceutical and biopharmaceutical research and development; providing scientific research information in the field of pharmaceuticals, biomedicine, clinical trials and post-market trials; cloud computing; providing temporary use of online non-downloadable computer software featuring electronic computer databases of pharmaceuticals, biomedicine, pharmaceutical and biopharmaceutical research and development, medical information, clinical trial and post-market trial data; providing temporary use of online non-downloadable computer software for research in the field of pharmaceuticals and biopharmaceuticals; providing temporary use of online non-downloadable computer software for compiling, accessing, controlling, managing and providing updated scientific, pharmaceutical, medical and clinical information, and news information of general interest; providing temporary use of non-downloadable software applications accessible via a web site for data analytics, financial analytics and risk management for use in the fields of pharmaceutical and biomedical research and development, clinical trials, and the provision of medical and healthcare services; application service provider featuring software for collecting, processing, storing, extracting, analyzing and transmitting clinical research data
FILING BASIS Section 44(d)
        FOREIGN APPLICATION NUMBER 08745/2019
       FOREIGN APPLICATION COUNTRY Switzerland
        FOREIGN FILING DATE 06/28/2019
GOODS AND/OR SERVICES SECTION (042)(proposed)
INTERNATIONAL CLASS 042
DESCRIPTION
Scientific and technological services and research and design relating thereto; analysis of technical data by computers; pharmaceutical, biomedical, biological therapeutic research services; research in the field of pharmaceutical and biologic therapeutic preparations; pharmaceutical and biopharmaceutical research and development; providing scientific research information in the field of pharmaceuticals, biomedicine, clinical trials and post-market trials; cloud computing; providing temporary use of online non-downloadable computer software featuring electronic computer databases of pharmaceuticals, biomedicine, pharmaceutical and biopharmaceutical research and development, medical information, clinical trial and post-market trial data; providing temporary use of online non-downloadable computer software for research in the field of pharmaceuticals and biopharmaceuticals; providing temporary use of online non-downloadable computer software for compiling, accessing, controlling, managing and providing updated scientific, pharmaceutical, medical and clinical information, and news information of general interest; providing temporary use of non-downloadable software applications accessible via a web site for data analytics, financial analytics and risk management for use in the fields of pharmaceutical and biomedical research and development, clinical trials, and the provision of medical and healthcare services; application service provider featuring software for collecting, processing, storing, extracting, analyzing and transmitting clinical research data
FILING BASIS Section 44(d)
       FOREIGN APPLICATION NUMBER 08745/2019
       FOREIGN APPLICATION COUNTRY Switzerland
       FOREIGN FILING DATE 06/28/2019
       INTENT TO
       PERFECT 44(d)
At this time, the applicant intends to rely on Section 44(e) as a basis for registration and requests that the application be suspended to await the submission of the foreign registration. If ultimately the applicant does not rely on §44(e) as a basis for registration, a valid claim of priority may be retained.
FILING BASIS Section 44(e)
       FOREIGN REGISTRATION NUMBER 740044
       FOREIGN REGISTRATION
       COUNTRY
Switzerland
       FOREIGN REGISTRATION
       DATE
12/11/2019
       FOREIGN EXPIRATION DATE 06/28/2029
       FOREIGN REGISTRATION FILE NAME(S)
       ORIGINAL PDF FILE FRU2-3810821634-093810290_._Swiss_registration_for_LOKAVANT__F3329004x96B9E_.pdf
       CONVERTED PDF FILE(S)
       (6 pages)
\\TICRS\EXPORT17\IMAGEOUT17\887\034\88703456\xml2\PRA0014.JPG
        \\TICRS\EXPORT17\IMAGEOUT17\887\034\88703456\xml2\PRA0015.JPG
        \\TICRS\EXPORT17\IMAGEOUT17\887\034\88703456\xml2\PRA0016.JPG
        \\TICRS\EXPORT17\IMAGEOUT17\887\034\88703456\xml2\PRA0017.JPG
        \\TICRS\EXPORT17\IMAGEOUT17\887\034\88703456\xml2\PRA0018.JPG
        \\TICRS\EXPORT17\IMAGEOUT17\887\034\88703456\xml2\PRA0019.JPG
       STANDARD CHARACTERS
       OR EQUIVALENT
YES
SIGNATURE SECTION
DECLARATION SIGNATURE The filing Attorney has elected not to submit the signed declaration, believing no supporting declaration is required under the Trademark Rules of Practice.
RESPONSE SIGNATURE /jmf/
SIGNATORY'S NAME Joyce M. Ferraro
SIGNATORY'S POSITION Attorney for Applicant, New York state bar member
SIGNATORY'S PHONE NUMBER 212-813-5900
DATE SIGNED 12/18/2019
AUTHORIZED SIGNATORY YES
FILING INFORMATION SECTION
SUBMIT DATE Wed Dec 18 10:15:08 EST 2019
TEAS STAMP USPTO/PRA-XX.XXX.XXX.XX-2
0191218101508286581-88703
456-70068b54e3029c03f3d5e
fe885f5070fe2369656f19ffe
9ef1a0ac7aa170347790-N/A-
N/A-20191218101258777624



Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1966 (Rev 10/2011)
OMB No. 0651-0050 (Exp 09/20/2020)

Voluntary Amendment


To the Commissioner for Trademarks:

Application serial no. 88703456 LOKAVANT(Standard Characters, see http://uspto.report/TM/88703456/mark.png) has been amended as follows:

CLASSIFICATION AND LISTING OF GOODS/SERVICES

Applicant proposes to amend the following class of goods/services in the application:
Current: Class 009 for Computer software; computer software for providing, analyzing and generating reports; computer software for data processing; software, programs and systems for the capture, collection, conversion, analysis, communication, processing, receiving, recording, storage and/or transmission of data, images and information; software, programs and systems for the conversion, analysis, processing, storage and transmission of artificial intelligence; computer software for database integration; computer software for creating searchable databases of information and data; software for analytics in the fields of healthcare, pharmaceuticals, biomedicine, pharmaceutical and biomedical research and development, and for clinical trial and post-market trial data; downloadable computer software featuring electronic computer databases of pharmaceuticals, biomedical research, and for clinical trial and post-market trial data; downloadable computer search engine software for compiling, accessing and providing updated scientific, medical, pharmaceutical, biomedical and clinical information, and news information of general interest; computer software for managing and analyzing clinical trial and clinical research workflow; computer software for use in collecting and managing data in the field of biomedical research; software for biomedical and clinical research services; database management software for use in biomedical and clinical and medical research
Original Filing Basis:
Filing Basis: Section 44(d), Priority based on foreign filing: For a trademark or service mark application: As of the application filing date, the applicant had a bona fide intention, and was entitled, to use the mark in commerce on or in connection with the identified goods/services, and asserts a claim of priority based upon a foreign application. For a collective trademark, collective service mark, or collective membership mark application: As of the application filing date, the applicant had a bona fide intention, and was entitled, to exercise legitimate control over the use of the mark in commerce by members on or in connection with the identified goods/services/collective membership organization, and asserts a claim of priority based upon a foreign application. For a certification application: As of the application filing date, the applicant had a bona fide intention, and was entitled, to exercise legitimate control over the use of the mark in commerce by authorized users in connection with the identified goods/services, the applicant will not engage in the production or marketing of the goods/services to which the mark is applied, except to advertise or promote recognition of the certification program or of the goods or services that meet the certification standards of the applicant, and the applicant asserts a claim of priority based upon a foreign application. Claim of priority is based on[ Switzerland application number 08745/2019 filed 06/28/2019]. 15 U.S.C.Section 1126(d), as amended.

Proposed: Class 009 for Computer software; computer software for providing, analyzing and generating reports; computer software for data processing; software, programs and systems for the capture, collection, conversion, analysis, communication, processing, receiving, recording, storage and/or transmission of data, images and information; software, programs and systems for the conversion, analysis, processing, storage and transmission of artificial intelligence; computer software for database integration; computer software for creating searchable databases of information and data; software for analytics in the fields of healthcare, pharmaceuticals, biomedicine, pharmaceutical and biomedical research and development, and for clinical trial and post-market trial data; downloadable computer software featuring electronic computer databases of pharmaceuticals, biomedical research, and for clinical trial and post-market trial data; downloadable computer search engine software for compiling, accessing and providing updated scientific, medical, pharmaceutical, biomedical and clinical information, and news information of general interest; computer software for managing and analyzing clinical trial and clinical research workflow; computer software for use in collecting and managing data in the field of biomedical research; software for biomedical and clinical research services; database management software for use in biomedical and clinical and medical research
Filing Basis: Section 44(d), Priority based on foreign filing:For a trademark or service mark application: As of the application filing date, the applicant had a bona fide intention, and was entitled, to use the mark in commerce on or in connection with the identified goods/services, and asserts a claim of priority based upon a foreign application. For a collective trademark, collective service mark, or collective membership mark application: As of the application filing date, the applicant had a bona fide intention, and was entitled, to exercise legitimate control over the use of the mark in commerce by members on or in connection with the identified goods/services/collective membership organization, and asserts a claim of priority based upon a foreign application. For a certification mark application: As of the application filing date, the applicant had a bona fide intention, and was entitled, to exercise legitimate control over the use of the mark in commerce by authorized users in connection with the identified goods/services, the applicant will not engage in the production or marketing of the goods/services to which the mark is applied, except to advertise or promote recognition of the certification program or of the goods or services that meet the certification standards of the applicant, and the applicant asserts a claim of priority based upon a foreign application. Claim of priority is based on [ Switzerland application number 08745/2019 filed 06/28/2019]. 15 U.S.C.Section 1126(d), as amended.
INTENT TO PERFECT 44(d) : At this time, the applicant intends to rely on Section 44(e) as a basis for registration and requests that the application be suspended to await the submission of the foreign registration. If ultimately the applicant does not rely on §44(e) as a basis for registration, a valid claim of priority may be retained.

Filing Basis: Section 44(e), Based on Foreign Registration:For all applications: The applicant attaches a copy of [ Switzerland registration number 740044 registered 12/11/2019 with a renewal date of __________ and an expiration date of 06/28/2029 ], and translation thereof, if appropriate. For a trademark or service mark application: As of the application filing date, the applicant had a bona fide intention, and was entitled, to use the mark in commerce on or in connection with the identified goods/services. For a collective trademark, collective service mark, or collective membership mark application: As of the application filing date, the applicant had a bona fide intention, and was entitled, to exercise legitimate control over the use of the mark in commerce by members on or in connection with the identified goods/services/collective membership organization. For a certification mark application: As of the application filing date, the applicant had a bona fide intention, and was entitled, to exercise legitimate control over the use of the mark in commerce by authorized users on or in connection with the identified goods/services, and the applicant will not engage in the production or marketing of the goods/services to which the mark is applied, except to advertise or promote recognition of the certification program or of the goods or services that meet the certification standards of the applicant.
Original PDF file:
FRU0-3810821634-093810290_._Swiss_registration_for_LOKAVANT__F3329004x96B9E_.pdf
Converted PDF file(s) ( 6 pages)
Foreign Registration-1
Foreign Registration-2
Foreign Registration-3
Foreign Registration-4
Foreign Registration-5
Foreign Registration-6

The foreign registration that is the basis of the U.S. application under §44(e) of the Trademark Act (15 U.S.C. §1126(e)) includes a claim of standard characters or the country of origin's standard character equivalent.

Applicant proposes to amend the following class of goods/services in the application:
Current: Class 035 for Advertising; business management; business administration; office functions; business research services; business information services; market research; provision of market research information; data processing services; analysis of business data; artificial intelligence and machine learning statistical analysis, consultancy and reporting for pharmaceutical and biomedical research; business analysis and statistical analysis of healthcare data, pharmaceuticals, biomedical research, and for clinical trial and post-market data; systematization and compilation of data in computer databases, in particular compilation of information into computer databases for research and analysis purposes in the field of healthcare, pharmaceuticals, biomedicine, pharmaceutical and biomedical research and development, clinical trials and post-market data; professional business analysis and consultancy and statistical analysis in the fields of healthcare, pharmaceuticals, biomedicine, clinical trials, epidemiological research, pharmacoepidemiological research, post-market trials and research evaluating epidemiological outcomes
Original Filing Basis:
Filing Basis: Section 44(d), Priority based on foreign filing: For a trademark or service mark application: As of the application filing date, the applicant had a bona fide intention, and was entitled, to use the mark in commerce on or in connection with the identified goods/services, and asserts a claim of priority based upon a foreign application. For a collective trademark, collective service mark, or collective membership mark application: As of the application filing date, the applicant had a bona fide intention, and was entitled, to exercise legitimate control over the use of the mark in commerce by members on or in connection with the identified goods/services/collective membership organization, and asserts a claim of priority based upon a foreign application. For a certification application: As of the application filing date, the applicant had a bona fide intention, and was entitled, to exercise legitimate control over the use of the mark in commerce by authorized users in connection with the identified goods/services, the applicant will not engage in the production or marketing of the goods/services to which the mark is applied, except to advertise or promote recognition of the certification program or of the goods or services that meet the certification standards of the applicant, and the applicant asserts a claim of priority based upon a foreign application. Claim of priority is based on[ Switzerland application number 08745/2019 filed 06/28/2019]. 15 U.S.C.Section 1126(d), as amended.

Proposed: Class 035 for Advertising; business management; business administration; office functions; business research services; business information services; market research; provision of market research information; data processing services; analysis of business data; artificial intelligence and machine learning statistical analysis, consultancy and reporting for pharmaceutical and biomedical research; business analysis and statistical analysis of healthcare data, pharmaceuticals, biomedical research, and for clinical trial and post-market data; systematization and compilation of data in computer databases, in particular compilation of information into computer databases for research and analysis purposes in the field of healthcare, pharmaceuticals, biomedicine, pharmaceutical and biomedical research and development, clinical trials and post-market data; professional business analysis and consultancy and statistical analysis in the fields of healthcare, pharmaceuticals, biomedicine, clinical trials, epidemiological research, pharmacoepidemiological research, post-market trials and research evaluating epidemiological outcomes
Filing Basis: Section 44(d), Priority based on foreign filing:For a trademark or service mark application: As of the application filing date, the applicant had a bona fide intention, and was entitled, to use the mark in commerce on or in connection with the identified goods/services, and asserts a claim of priority based upon a foreign application. For a collective trademark, collective service mark, or collective membership mark application: As of the application filing date, the applicant had a bona fide intention, and was entitled, to exercise legitimate control over the use of the mark in commerce by members on or in connection with the identified goods/services/collective membership organization, and asserts a claim of priority based upon a foreign application. For a certification mark application: As of the application filing date, the applicant had a bona fide intention, and was entitled, to exercise legitimate control over the use of the mark in commerce by authorized users in connection with the identified goods/services, the applicant will not engage in the production or marketing of the goods/services to which the mark is applied, except to advertise or promote recognition of the certification program or of the goods or services that meet the certification standards of the applicant, and the applicant asserts a claim of priority based upon a foreign application. Claim of priority is based on [ Switzerland application number 08745/2019 filed 06/28/2019]. 15 U.S.C.Section 1126(d), as amended.
INTENT TO PERFECT 44(d) : At this time, the applicant intends to rely on Section 44(e) as a basis for registration and requests that the application be suspended to await the submission of the foreign registration. If ultimately the applicant does not rely on §44(e) as a basis for registration, a valid claim of priority may be retained.

Filing Basis: Section 44(e), Based on Foreign Registration:For all applications: The applicant attaches a copy of [ Switzerland registration number 740044 registered 12/11/2019 with a renewal date of __________ and an expiration date of 06/28/2029 ], and translation thereof, if appropriate. For a trademark or service mark application: As of the application filing date, the applicant had a bona fide intention, and was entitled, to use the mark in commerce on or in connection with the identified goods/services. For a collective trademark, collective service mark, or collective membership mark application: As of the application filing date, the applicant had a bona fide intention, and was entitled, to exercise legitimate control over the use of the mark in commerce by members on or in connection with the identified goods/services/collective membership organization. For a certification mark application: As of the application filing date, the applicant had a bona fide intention, and was entitled, to exercise legitimate control over the use of the mark in commerce by authorized users on or in connection with the identified goods/services, and the applicant will not engage in the production or marketing of the goods/services to which the mark is applied, except to advertise or promote recognition of the certification program or of the goods or services that meet the certification standards of the applicant.
Original PDF file:
FRU1-3810821634-093810290_._Swiss_registration_for_LOKAVANT__F3329004x96B9E_.pdf
Converted PDF file(s) ( 6 pages)
Foreign Registration-1
Foreign Registration-2
Foreign Registration-3
Foreign Registration-4
Foreign Registration-5
Foreign Registration-6

The foreign registration that is the basis of the U.S. application under §44(e) of the Trademark Act (15 U.S.C. §1126(e)) includes a claim of standard characters or the country of origin's standard character equivalent.

Applicant proposes to amend the following class of goods/services in the application:
Current: Class 042 for Scientific and technological services and research and design relating thereto; analysis of technical data by computers; pharmaceutical, biomedical, biological therapeutic research services; research in the field of pharmaceutical and biologic therapeutic preparations; pharmaceutical and biopharmaceutical research and development; providing scientific research information in the field of pharmaceuticals, biomedicine, clinical trials and post-market trials; cloud computing; providing temporary use of online non-downloadable computer software featuring electronic computer databases of pharmaceuticals, biomedicine, pharmaceutical and biopharmaceutical research and development, medical information, clinical trial and post-market trial data; providing temporary use of online non-downloadable computer software for research in the field of pharmaceuticals and biopharmaceuticals; providing temporary use of online non-downloadable computer software for compiling, accessing, controlling, managing and providing updated scientific, pharmaceutical, medical and clinical information, and news information of general interest; providing temporary use of non-downloadable software applications accessible via a web site for data analytics, financial analytics and risk management for use in the fields of pharmaceutical and biomedical research and development, clinical trials, and the provision of medical and healthcare services; application service provider featuring software for collecting, processing, storing, extracting, analyzing and transmitting clinical research data
Original Filing Basis:
Filing Basis: Section 44(d), Priority based on foreign filing: For a trademark or service mark application: As of the application filing date, the applicant had a bona fide intention, and was entitled, to use the mark in commerce on or in connection with the identified goods/services, and asserts a claim of priority based upon a foreign application. For a collective trademark, collective service mark, or collective membership mark application: As of the application filing date, the applicant had a bona fide intention, and was entitled, to exercise legitimate control over the use of the mark in commerce by members on or in connection with the identified goods/services/collective membership organization, and asserts a claim of priority based upon a foreign application. For a certification application: As of the application filing date, the applicant had a bona fide intention, and was entitled, to exercise legitimate control over the use of the mark in commerce by authorized users in connection with the identified goods/services, the applicant will not engage in the production or marketing of the goods/services to which the mark is applied, except to advertise or promote recognition of the certification program or of the goods or services that meet the certification standards of the applicant, and the applicant asserts a claim of priority based upon a foreign application. Claim of priority is based on[ Switzerland application number 08745/2019 filed 06/28/2019]. 15 U.S.C.Section 1126(d), as amended.

Proposed: Class 042 for Scientific and technological services and research and design relating thereto; analysis of technical data by computers; pharmaceutical, biomedical, biological therapeutic research services; research in the field of pharmaceutical and biologic therapeutic preparations; pharmaceutical and biopharmaceutical research and development; providing scientific research information in the field of pharmaceuticals, biomedicine, clinical trials and post-market trials; cloud computing; providing temporary use of online non-downloadable computer software featuring electronic computer databases of pharmaceuticals, biomedicine, pharmaceutical and biopharmaceutical research and development, medical information, clinical trial and post-market trial data; providing temporary use of online non-downloadable computer software for research in the field of pharmaceuticals and biopharmaceuticals; providing temporary use of online non-downloadable computer software for compiling, accessing, controlling, managing and providing updated scientific, pharmaceutical, medical and clinical information, and news information of general interest; providing temporary use of non-downloadable software applications accessible via a web site for data analytics, financial analytics and risk management for use in the fields of pharmaceutical and biomedical research and development, clinical trials, and the provision of medical and healthcare services; application service provider featuring software for collecting, processing, storing, extracting, analyzing and transmitting clinical research data
Filing Basis: Section 44(d), Priority based on foreign filing:For a trademark or service mark application: As of the application filing date, the applicant had a bona fide intention, and was entitled, to use the mark in commerce on or in connection with the identified goods/services, and asserts a claim of priority based upon a foreign application. For a collective trademark, collective service mark, or collective membership mark application: As of the application filing date, the applicant had a bona fide intention, and was entitled, to exercise legitimate control over the use of the mark in commerce by members on or in connection with the identified goods/services/collective membership organization, and asserts a claim of priority based upon a foreign application. For a certification mark application: As of the application filing date, the applicant had a bona fide intention, and was entitled, to exercise legitimate control over the use of the mark in commerce by authorized users in connection with the identified goods/services, the applicant will not engage in the production or marketing of the goods/services to which the mark is applied, except to advertise or promote recognition of the certification program or of the goods or services that meet the certification standards of the applicant, and the applicant asserts a claim of priority based upon a foreign application. Claim of priority is based on [ Switzerland application number 08745/2019 filed 06/28/2019]. 15 U.S.C.Section 1126(d), as amended.
INTENT TO PERFECT 44(d) : At this time, the applicant intends to rely on Section 44(e) as a basis for registration and requests that the application be suspended to await the submission of the foreign registration. If ultimately the applicant does not rely on §44(e) as a basis for registration, a valid claim of priority may be retained.

Filing Basis: Section 44(e), Based on Foreign Registration:For all applications: The applicant attaches a copy of [ Switzerland registration number 740044 registered 12/11/2019 with a renewal date of __________ and an expiration date of 06/28/2029 ], and translation thereof, if appropriate. For a trademark or service mark application: As of the application filing date, the applicant had a bona fide intention, and was entitled, to use the mark in commerce on or in connection with the identified goods/services. For a collective trademark, collective service mark, or collective membership mark application: As of the application filing date, the applicant had a bona fide intention, and was entitled, to exercise legitimate control over the use of the mark in commerce by members on or in connection with the identified goods/services/collective membership organization. For a certification mark application: As of the application filing date, the applicant had a bona fide intention, and was entitled, to exercise legitimate control over the use of the mark in commerce by authorized users on or in connection with the identified goods/services, and the applicant will not engage in the production or marketing of the goods/services to which the mark is applied, except to advertise or promote recognition of the certification program or of the goods or services that meet the certification standards of the applicant.
Original PDF file:
FRU2-3810821634-093810290_._Swiss_registration_for_LOKAVANT__F3329004x96B9E_.pdf
Converted PDF file(s) ( 6 pages)
Foreign Registration-1
Foreign Registration-2
Foreign Registration-3
Foreign Registration-4
Foreign Registration-5
Foreign Registration-6

The foreign registration that is the basis of the U.S. application under §44(e) of the Trademark Act (15 U.S.C. §1126(e)) includes a claim of standard characters or the country of origin's standard character equivalent.

SIGNATURE(S)
Declaration Signature
The filing Attorney has elected not to submit the signed declaration, believing no supporting declaration is required under the Trademark Rules of Practice.
Voluntary Amendment Signature
Signature: /jmf/     Date: 12/18/2019
Signatory's Name: Joyce M. Ferraro
Signatory's Position: Attorney for Applicant, New York state bar member

Signatory's Phone Number: 212-813-5900

The signatory has confirmed that he/she is a U.S.-licensed attorney who is an active member in good standing of the bar of the highest court of a U.S. state (including the District of Columbia and any U.S. Commonwealth or territory); and he/she is currently the owner's/holder's attorney or an associate thereof; and to the best of his/her knowledge, if prior to his/her appointment another U.S.-licensed attorney not currently associated with his/her company/firm previously represented the owner/holder in this matter: the owner/holder has revoked their power of attorney by a signed revocation or substitute power of attorney with the USPTO; the USPTO has granted that attorney's withdrawal request; the owner/holder has filed a power of attorney appointing him/her in this matter; or the owner's/holder's appointed U.S.-licensed attorney has filed a power of attorney appointing him/her as an associate attorney in this matter.

        
Serial Number: 88703456
Internet Transmission Date: Wed Dec 18 10:15:08 EST 2019
TEAS Stamp: USPTO/PRA-XX.XXX.XXX.XX-2019121810150828
6581-88703456-70068b54e3029c03f3d5efe885
f5070fe2369656f19ffe9ef1a0ac7aa170347790
-N/A-N/A-20191218101258777624


Preliminary Amendment [image/jpeg]

Preliminary Amendment [image/jpeg]

Preliminary Amendment [image/jpeg]

Preliminary Amendment [image/jpeg]

Preliminary Amendment [image/jpeg]

Preliminary Amendment [image/jpeg]

Preliminary Amendment [image/jpeg]

Preliminary Amendment [image/jpeg]

Preliminary Amendment [image/jpeg]

Preliminary Amendment [image/jpeg]

Preliminary Amendment [image/jpeg]

Preliminary Amendment [image/jpeg]

Preliminary Amendment [image/jpeg]

Preliminary Amendment [image/jpeg]

Preliminary Amendment [image/jpeg]

Preliminary Amendment [image/jpeg]

Preliminary Amendment [image/jpeg]

Preliminary Amendment [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed